JPS6035266A - 多種抗体検出用混合マイクロカプセル及びその製造方法 - Google Patents
多種抗体検出用混合マイクロカプセル及びその製造方法Info
- Publication number
- JPS6035266A JPS6035266A JP14358983A JP14358983A JPS6035266A JP S6035266 A JPS6035266 A JP S6035266A JP 14358983 A JP14358983 A JP 14358983A JP 14358983 A JP14358983 A JP 14358983A JP S6035266 A JPS6035266 A JP S6035266A
- Authority
- JP
- Japan
- Prior art keywords
- microcapsule
- antigen
- sensitivity
- microcapsules
- sensitized
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003094 microcapsule Substances 0.000 title claims abstract description 63
- 238000001514 detection method Methods 0.000 title abstract description 3
- 238000007689 inspection Methods 0.000 title 1
- 239000000427 antigen Substances 0.000 claims abstract description 54
- 102000036639 antigens Human genes 0.000 claims abstract description 54
- 108091007433 antigens Proteins 0.000 claims abstract description 54
- 230000035945 sensitivity Effects 0.000 claims abstract description 45
- 238000002156 mixing Methods 0.000 claims abstract description 7
- 238000012360 testing method Methods 0.000 claims description 11
- 241000589902 Leptospira Species 0.000 claims description 6
- 238000006243 chemical reaction Methods 0.000 claims description 5
- 238000010998 test method Methods 0.000 claims 2
- 230000001747 exhibiting effect Effects 0.000 claims 1
- 230000004520 agglutination Effects 0.000 abstract description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 36
- 238000000034 method Methods 0.000 description 12
- 239000000243 solution Substances 0.000 description 9
- 230000001580 bacterial effect Effects 0.000 description 8
- 206010070834 Sensitisation Diseases 0.000 description 7
- 239000002504 physiological saline solution Substances 0.000 description 7
- 230000008313 sensitization Effects 0.000 description 7
- 230000001235 sensitizing effect Effects 0.000 description 7
- 241000894006 Bacteria Species 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 4
- 238000010790 dilution Methods 0.000 description 4
- 239000012895 dilution Substances 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 241000283973 Oryctolagus cuniculus Species 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 2
- 241000272791 Dendrocygna autumnalis Species 0.000 description 2
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 230000002776 aggregation Effects 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 239000007975 buffered saline Substances 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 210000003850 cellular structure Anatomy 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000005484 gravity Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 235000018185 Betula X alpestris Nutrition 0.000 description 1
- 235000018212 Betula X uliginosa Nutrition 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 108010093096 Immobilized Enzymes Proteins 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 241000204031 Mycoplasma Species 0.000 description 1
- 206010035148 Plague Diseases 0.000 description 1
- 241000607768 Shigella Species 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 241000223996 Toxoplasma Species 0.000 description 1
- 241000589884 Treponema pallidum Species 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 241000607626 Vibrio cholerae Species 0.000 description 1
- 235000010724 Wisteria floribunda Nutrition 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 238000005660 chlorination reaction Methods 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- 230000009260 cross reactivity Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000000586 desensitisation Methods 0.000 description 1
- 239000002274 desiccant Substances 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 239000002359 drug metabolite Substances 0.000 description 1
- UPBDXRPQPOWRKR-UHFFFAOYSA-N furan-2,5-dione;methoxyethene Chemical compound COC=C.O=C1OC(=O)C=C1 UPBDXRPQPOWRKR-UHFFFAOYSA-N 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 150000004712 monophosphates Chemical class 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 238000011056 performance test Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 239000001044 red dye Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000000527 sonication Methods 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 229940118696 vibrio cholerae Drugs 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP14358983A JPS6035266A (ja) | 1983-08-05 | 1983-08-05 | 多種抗体検出用混合マイクロカプセル及びその製造方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP14358983A JPS6035266A (ja) | 1983-08-05 | 1983-08-05 | 多種抗体検出用混合マイクロカプセル及びその製造方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS6035266A true JPS6035266A (ja) | 1985-02-23 |
| JPH056665B2 JPH056665B2 (enrdf_load_stackoverflow) | 1993-01-27 |
Family
ID=15342243
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP14358983A Granted JPS6035266A (ja) | 1983-08-05 | 1983-08-05 | 多種抗体検出用混合マイクロカプセル及びその製造方法 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS6035266A (enrdf_load_stackoverflow) |
-
1983
- 1983-08-05 JP JP14358983A patent/JPS6035266A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPH056665B2 (enrdf_load_stackoverflow) | 1993-01-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5154445B2 (ja) | 抗赤血球アロ抗体の多重検出 | |
| JPS6314783B2 (enrdf_load_stackoverflow) | ||
| US4711841A (en) | Method for determining one or more antigens in a sample | |
| EP0311492B1 (fr) | Trousse et méthode de dosage immunométrique applicables à des cellules entières | |
| JPH0370787B2 (enrdf_load_stackoverflow) | ||
| CA2565114A1 (fr) | Utilisation de ferrofluides pour le phenotypage sanguin et applications derivees | |
| EP1709451B1 (en) | Reducing time to result for blood bank diagnostic testing | |
| TWI757328B (zh) | 使用以相異方式將抗原固定化之承載抗原不溶性承載粒子之抗體測定法、抗體測定用試劑 | |
| CA1226217A (en) | Diagnostic reagent for rheumatoid factor, process for its preparation and method and kit for its use | |
| JPS6314911B2 (enrdf_load_stackoverflow) | ||
| JPS6035266A (ja) | 多種抗体検出用混合マイクロカプセル及びその製造方法 | |
| JPS6058420B2 (ja) | 免疫反応用マイクロカプセル群及びそれを用いた判別方法 | |
| JP2735642B2 (ja) | 抗体固定化不溶性担体粒子 | |
| JP3804817B2 (ja) | 抗体測定試薬及びその製造法 | |
| JP2684425B2 (ja) | ラテックス試薬 | |
| CN113125714B (zh) | 一种人类免疫缺陷病毒抗体检测试剂盒及其应用 | |
| CN103097893B (zh) | 甘油磷脂的稳定化方法及使用该方法的试剂 | |
| RU2228764C2 (ru) | Способ получения суспензионного диагностикума (варианты) | |
| JPH01152366A (ja) | 免疫学的診断用試薬 | |
| JPS6035267A (ja) | 多項目免疫検査法 | |
| JP3095541B2 (ja) | 免疫学的凝集反応試薬の製造方法 | |
| JPS6035268A (ja) | 免疫反応用マイクロカプセル試薬及びこれを用いる検査法 | |
| JP2852656B2 (ja) | ヒト免疫不全ウイルス２型抗原の製造方法及びそれを用いた該抗体の検出用試薬 | |
| JPH07113641B2 (ja) | 梅毒診断試薬の製造方法 | |
| JP4005093B2 (ja) | Ｃ型肝炎ウイルス感染症診断薬および抗ｈｃｖ抗体検出方法 |